IPP Bureau
FDA nod to first oral single-dose treatment for gonorrhea
By IPP Bureau - December 16, 2025
The approval of Nuzolvence (zoliflodacin) follows a collaborative development effort with the Global Antibiotic Research and Development Partnership
Accenture invests in Ryght AI to revolutionize clinical trials
By IPP Bureau - December 16, 2025
Ryght AI tackles these hurdles with its AI Site Twin platform
FDA accepts Sentynl Therapeutics CUTX-101 NDA resubmission
By IPP Bureau - December 16, 2025
If approved, CUTX-101 will be the first and only FDA approved treatment available for Menkes disease
Ind-Swift Laboratories receives GMP compliance certificate from NNGYK-Hungary
By IPP Bureau - December 16, 2025
The said certificate is valid for a period of 3 years and opens up the European and other markets for the company's products
KIMS Hospital Bengaluru commences operations at PES University campus
By IPP Bureau - December 16, 2025
The state-of-the-art facility is a 350-bedded, multi-specialty tertiary care hospital
Shelter Pharma launches D3 cure capsules
By IPP Bureau - December 16, 2025
This launch is part of the company's strategy to expand its nutraceutical portfolio
Biocon launches its Glucagon-like Peptide-1, Liraglutide, in the Netherlands
By IPP Bureau - December 16, 2025
Godavari Biorefineries ED Sangeeta Srivastava named BRSI Honorary Fellow
By IPP Bureau - December 16, 2025
Dr Srivastava was selected by an expert jury in recognition of her sustained contributions to renewable chemicals, industrial biotechnology and bioprocess innovation
Caplin Point Laboratories’ injectables facility completes INVIMA audit successfully
By IPP Bureau - December 15, 2025
This is also an important milestone in our product strategy for our expansion into the larger Latin American market
Indoco receives EIR from the USFDA for its API manufacturing facility at Patalganga
By IPP Bureau - December 15, 2025
Indoco received the Establishment Inspection Report from the USFDA for its API manufacturing facility
Eiko LifeSciences to acquire 51% stake in SSM Formulations
By IPP Bureau - December 15, 2025
The plant can reach an annual capacity of 300 crore tablets and 90 crore capsules
Anil Koul joins Mankind Pharma as Group Chief Scientific Officer
By IPP Bureau - December 15, 2025
More than five drug candidates from his team progressed to human trials including drugs like Rilematovir (Phase IIb), and Bedaquiline
Akums launches advanced Gabapentin ER for PHN management with RetenEx technology
By IPP Bureau - December 15, 2025
Thermo Fisher Scientific appoints Anoopa Menon as Director
By IPP Bureau - December 14, 2025
In her previous roles, Menon led significant digital transformation efforts, implementing predictive analytics, automation
